{"disease":{"id":"pancreatic-cancer-non-resectable","name":"pancreatic cancer non resectable"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06670547","title":"Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde Cholangiopancreatography","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Germans Trias i Pujol Hospital","has_results":false},{"nct_id":"NCT06388967","title":"Pancreatic Cancer Detection Consortium","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT06073431","title":"LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"University of Rochester","has_results":false},{"nct_id":"NCT06453590","title":"Treatment of Distal Malignant Biliary Obstruction by Uncovered, Partially Covered, or Fully Covered Metal Stents","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":450,"lead_sponsor_name":"Region Stockholm","has_results":false},{"nct_id":"NCT03590275","title":"Observational Retrospective Study of Evaluation of Prognostic Factors in Advanced Pancreatic Cancer Patients Treated With FOLFIRINOX","phase":"","overall_status":"COMPLETED","enrollment_count":343,"lead_sponsor_name":"Azienda Ospedaliero, Universitaria Pisana","has_results":false},{"nct_id":"NCT05802485","title":"PANCREATIC CANCER: DYNAMIC ASSESSMENT AT ALL STAGES OF TREATMENT","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Institut Paoli-Calmettes","has_results":false},{"nct_id":"NCT03941093","title":"Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":284,"lead_sponsor_name":"Kyntra Bio","has_results":true},{"nct_id":"NCT05524090","title":"PREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":223,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT02498613","title":"A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":122,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT03063554","title":"EUS BD vs ERCP TP for Pancreatic Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":false},{"nct_id":"NCT03984214","title":"Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":109,"lead_sponsor_name":"Arbeitsgemeinschaft medikamentoese Tumortherapie","has_results":false},{"nct_id":"NCT03964064","title":"I125 Seed Implantation vs Stereotactic Radiotherapy for Pancreatic Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT07271823","title":"Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Zhejiang Cancer Hospital","has_results":false},{"nct_id":"NCT06090916","title":"Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pancreatic Cancer","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Jonsson Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT05265663","title":"Stereotactic Radiotherapy vs Best Supportive Care in Unfit Pancreatic Cancer Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":98,"lead_sponsor_name":"Amsterdam UMC, location VUmc","has_results":false},{"nct_id":"NCT06160323","title":"Upfront EUS CGN/CPN vs Conventional Step up Approach for Inoperable Painful Pancreatic Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":94,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT04986930","title":"mFOLFIRINOX With or Without Stereotactic Body Radiotherapy in Locally Advanced Pancreatic Adenocarcinoma","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":92,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT07326150","title":"Construction of a Predictive Model for the Efficacy of Chemoprevention Combined With Targeted Therapy in Pancreatic Cancer","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":70,"lead_sponsor_name":"Zhejiang Cancer Hospital","has_results":false},{"nct_id":"NCT06840067","title":"Clinical Study of Carbon Ion Radiotherapy for Pancreatic Cancer.","phase":"NA","overall_status":"RECRUITING","enrollment_count":62,"lead_sponsor_name":"Gansu Wuwei Tumor Hospital","has_results":false},{"nct_id":"NCT02495896","title":"Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":61,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT07066995","title":"Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Essen Biotech","has_results":false},{"nct_id":"NCT04338763","title":"RP72 Monotherapy and in Combination With Gemcitabine in Patients With Pancreatic Cancer","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":48,"lead_sponsor_name":"Rise Biopharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT06916975","title":"Adebrelimab Combined With AG Regimen in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":46,"lead_sponsor_name":"Jin Xu","has_results":false},{"nct_id":"NCT06361030","title":"Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic Cancer","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT06888648","title":"Personalized Tumor Neoantigen MRNA Therapy for Advanced Pancreatic Cancer.","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Zhejiang University","has_results":false},{"nct_id":"NCT06503497","title":"A Trail of Second-line Chemotherapy Sequential NKG2D CAR-NK Cell Therapy for Pancreatic Cancer","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Zhejiang University","has_results":false},{"nct_id":"NCT03165591","title":"Open Label Immunotherapy Trial of Inoperable Pancreatic Cancer","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Immunitor LLC","has_results":false},{"nct_id":"NCT07386704","title":"Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer","phase":"PHASE2","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30,"lead_sponsor_name":"Peking University First Hospital","has_results":false},{"nct_id":"NCT07302841","title":"Tunlametinib + AG + Cetuximab β as First-Line Therapy for Advanced Pancreatic Cancer","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":28,"lead_sponsor_name":"Tianjin Medical University Cancer Institute and Hospital","has_results":false},{"nct_id":"NCT06937996","title":"Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System-","phase":"","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"Englewood Hospital and Medical Center","has_results":false},{"nct_id":"NCT04116073","title":"INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":true},{"nct_id":"NCT06478459","title":"Endoscopic Ultrasound (EUS) Intratumoral Injection of CAR-NK Cells in the Treatment of Advanced Pancreatic Cancer","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Zhejiang University","has_results":false},{"nct_id":"NCT05642962","title":"Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":17,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT04156087","title":"Progression-free Survival After MWA Plus Durvalumab and Tremelimumab for Unresectable Locally Advanced Pancreatic Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Baki Topal","has_results":false},{"nct_id":"NCT02128100","title":"Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"University of Louisville","has_results":true},{"nct_id":"NCT04852367","title":"PanDox: Targeted Doxorubicin in Pancreatic Tumours","phase":"PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of Oxford","has_results":false}],"total":36},"guidelines":[],"source":"Drug Landscape verified database"}